Upadacitinib in Crohn's Disease: A Comprehensive Systematic Review of Efficacy and Safety.
Wodeyar AM, Pansuriya N, Saeed S, Lakhani A, Sartaj S, Keerthi NSJ, Guntur Bhuvika Raji A, S B, Wahane V, Thapa Y, Abriha F.
Wodeyar AM, et al. Among authors: s b.
Cureus. 2023 Dec 17;15(12):e50657. doi: 10.7759/cureus.50657. eCollection 2023 Dec.
Cureus. 2023.
PMID: 38229787
Free PMC article.
Review.
Crohn's disease (CD) presents a formidable challenge as a chronic inflammatory condition. This systematic review aimed to comprehensively assess upadacitinib, a novel Janus kinase (JAK) inhibitor, regarding its efficacy, safety, and mechanistic insights in CD treatment. .. …
Crohn's disease (CD) presents a formidable challenge as a chronic inflammatory condition. This systematic review aimed to comprehensi …